9 results match your criteria: "From the Massachusetts Institute of Technology[Affiliation]"
J Law Med Ethics
December 2019
Christopher J. Morten, J.D., Ph.D., is a Fellow of the Engelberg Center on Innovation Law & Policy and the Teaching Fellow and Supervising Attorney in the Technology Law & Policy Clinic at New York University School of Law. He is also a Visiting Fellow of the Information Society Project at Yale Law School. He received his JD from NYU Law, a PhD in organic chemistry from the Massachusetts Institute of Technology, and a BA in chemistry from Columbia University. Aaron S. Kesselheim, M.D., J.D., M.P.H., is a Professor of Medicine at Harvard Medical School and Director of the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. His work is funded by Arnold Ventures, the Harvard-MIT Center for Regulatory Science, and the Engelberg Foundation. Joseph S. Ross, M.D., M.H.S., is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management) at the Yale School of Medicine, a member of the Center for Outcomes Research and Evaluation at Yale-New Haven Health System, and Co-Director of the National Clinician Scholars Program at Yale.
N Engl J Med
January 2020
From the Massachusetts Institute of Technology (A.F., J.D.) and the National Bureau of Economic Research (A.Z., S.T.) - both in Cambridge.
Background: There is widespread interest in programs aiming to reduce spending and improve health care quality among "superutilizers," patients with very high use of health care services. The "hotspotting" program created by the Camden Coalition of Healthcare Providers (hereafter, the Coalition) has received national attention as a promising superutilizer intervention and has been expanded to cities around the country. In the months after hospital discharge, a team of nurses, social workers, and community health workers visits enrolled patients to coordinate outpatient care and link them with social services.
View Article and Find Full Text PDFJ Law Med Ethics
June 2018
Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.
As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to "value-based" payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.
View Article and Find Full Text PDFAnesth Analg
August 2018
Department of Anesthesiology, Mayo Clinic Arizona, Phoenix, Arizona.
Unrecognized pregnancy in patients presenting for elective surgery is of particular concern due to the potential for significant complications. Accurate and inexpensive urine pregnancy tests are widely available in the developed world. As a result, universal preoperative pregnancy screening is commonly implemented.
View Article and Find Full Text PDFJ Law Med Ethics
December 2016
Peter Shin, Ph.D., is the Director of the Geiger Gibson Program in Community Health Policy, the Research Director of the Ryan Community Health Network (RCHN) Community Health Foundation, and an Associate Professor in the Department of Health Policy and Management at the Milken Institute School of Public Health at the George Washington University. Dr. Shin received his Bachelor of Arts from Oberlin College (Oberlin, OH), his Master of Public Health with concentration in epidemiology from the George Washington University (Washington, D.C.) and his Ph.D. in Public Policy from the George Washington University (Washington, D.C.). Marsha Regenstein, Ph.D., is a Professor in the Department of Health Policy and Management at the Milken Institute School of Public Health within the George Washington University. She is the DrPH Program Director for the Milken Institute School of Public Health. Dr. Regenstein received her Bachelor of Arts from Brandeis, University (Waltham, MA), her Master of City Planning from the Massachusetts Institute of Technology (Cambridge, MA), and her Ph.D. in public policy with a health concentration from the George Washington University (Washington, D.C.).
Two major safety net providers - community health centers and public hospitals - continue to play a key role in the health care system even in the wake of coverage reform. This article examines the gains and threats they face under the Affordable Care Act.
View Article and Find Full Text PDFIEEE Signal Process Mag
September 2013
Department of Computer Science and Engineering, University of California, San Diego. She received a bachelor of technology degree in computer science and engineering from the Indian Institute of Technology, Kanpur, in 2002, and a Ph.D. degree in computer science from the University of California at Berkeley in 2007. Her research focuses on the design and analysis of machine-learning algorithms and their applications. In particular, she is interested in privacy-preserving machine learning, where the goal is to develop machine-learning methods for sensitive data while still preserving the privacy of the individuals in the data set. ( ).
Plast Reconstr Surg
January 2011
Cambridge and Boston, Mass. From the Massachusetts Institute of Technology; Brigham and Women's Hospital, Harvard Medical School; and Massachusetts General Hospital.
Background: Advances in critical care allowed survival of large total body surface burn patients in the 1970s, spawning the development of artificial skin for burn victims. Lack of dermis resulted in severe scarring and contractures. The physicochemical properties that are critical to dermal regeneration have subsequently been described, and a dermal regeneration template has been developed.
View Article and Find Full Text PDFJ Biol Chem
October 2010
From the Massachusetts Institute of Technology, Picower Institute for Learning and Memory, the Howard Hughes Medical Institute, Cambridge, Massachusetts 02139, the Stanley Center for Psychiatric Research; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts 02139. Electronic address:
Organogenesis is a highly integrated process with a fundamental requirement for precise cell cycle control. Mechanistically, the cell cycle is composed of transitions and thresholds that are controlled by coordinated post-translational modifications. In this study, we describe a novel mechanism controlling the persistence of the transcription factor ATF4 by multisite phosphorylation.
View Article and Find Full Text PDF